Simultaneously. Starts softPAP Cervical Cell Collector in SpainCytoCore Inc. , the biopharmaceutical research and medical device company for early detection and treatment of reproductive tract cancers, today announced its first order and shipment of softPAP cell collector Palex Medical SA.
The Company’s business These factors include, among others, risks and uncertainties for the regular public filings with the Securities and Exchange Commission, including in-depth, but not to the Company’s Annual Report on Form 10-K for the year ended 31st December 2006 limited. Except as expressly required by law, assumes no obligation to CytoCore publicly update or revise any forward-looking statements in this document.. Certain statements in this news release are forward-looking statements.There are approximately between 300 to 500 million incidence of malaria every year, that at over 90 several countries, according to the World Health Organisation. – Dr Paul Hunt, on the University of Edinburgh School of Biological Sciences, said: Such knowledge of rodent malarial parasites opening up new ways in which investigated investigated to human malaria This can help track the development of drugs resistance resistance and can be ultimately design of alternative, potent drugs. . The trial that was published in BMC Genomics , was funded by Medical Research Council.
The identification said gene paves the way for further studies, to able including help you controlling development of resistance to artemisinin and lead to more potent drugs for human malaria.